Browsing by Author "Ruiz Camps, Isabel"
Now showing items 1-10 of 10
-
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
Muntañola, Ana; Villacampa Javierre, Guillermo; Hernández‑Rivas, José Ángel; Alonso, Rosalía; Mirás, Fátima; Osorio, Santiago; Crespo Maull, Marta; Sánchez Montalvá, Adrián; Ruiz Camps, Isabel; Abrisqueta Costa, Pablo; Bosch Albareda, Francesc (BMC, 2020-12-18) -
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
Grau, Santiago; Azanza, Jose Ramon; Ruiz Camps, Isabel; Vallejo, Carlos; Mensa, Josep; Maertens, Johan (Dove Medical Press, 2016-12-30) -
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Garrigós Cubells, Laia; Saura Manich, Cristina; Martinez-Vila, Clara; Zambelli, Alberto; Bower, Mark; Pistilli, Barbara; Aguilar Company, Juan; Ruiz Camps, Isabel (SAGE Publications, 2021-11-02) -
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
Albasanz-Puig, Adaia; Gudiol, Carlota; Parody, Rocío; Tebé-Cordomí, Cristian; Akova, Murat; Araos, Rafael; Ruiz Camps, Isabel (BMJ Publishing Group, 2019-05-24) -
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
Bellet Ezquerra, Meritxell; Ahmad Diaz, Faten; Villanueva, Rafael; Valdivia Vadell, Carolina; Palomino-Doza, Julián; Ruiz, Ada; Azaro Pedrazzoli, Analía Beatriz; Aguilar Company, Juan; Martín Pérez, Anastasio; Escriva de Romaní Muñoz, Santiago Ignacio; Reyes López, Victoria; Alcalde Rodrigo, Maria; Ruiz Camps, Isabel (SAGE Publications, 2019-05-10) -
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
Pinato, David J.; Lee, Alvin J. X.; Biello, Federica; Seguí, Elia; Aguilar Company, Juan; Carbó, Anna; Ruiz Camps, Isabel; Tabernero Caturla, Josep (MDPI, 2020-07-08) -
Risk of infection associated with targeted therapies for solid organ and hematological malignancies
Ruiz Camps, Isabel; Aguilar Company, Juan (SAGE Publications, 2021-02-19) -
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Soosaipillai, Gehan; Wu, Anjui; Dettorre, Gino M; Diamantis, Nikolaos; Chester, John; Moss, Charlotte; Aguilar Company, Juan; Saoudi Gonzalez, Nadia; Ruiz Camps, Isabel; Cabirta, Alba; Tabernero Caturla, Josep (SAGE Publications, 2021-09-02) -
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Dettorre, Gino M; Dolly, Saoirse; Loizidou, Angela; Chester, John; Jackson, Amanda; Mukherjee, Uma; Aguilar Company, Juan; Mirallas Viñas, Oriol; Saoudi Gonzalez, Nadia; García Illescas, David; Ruiz Camps, Isabel; Tabernero Caturla, Josep (BMJ Publishing Group, 2021-03-22) -
Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
López Sánchez, Cristina; Valcarcel Ferreiras, David; Gómez, Valle; López-Jiménez, Javier; Serrano, David; Rubio, Vicente; Ruiz Camps, Isabel (Sociedad Española de Quimioterapia, 2020-04)